On December 8, 2025, Achieve Life Sciences, Inc., operating out of Seattle and Vancouver, British Columbia, shared that they have granted stock options to Erik Atkisson, the Chief Legal Officer, as well as additional new employees. The company, listed on Nasdaq as ACHV, specializes in developing and marketing cytisinicline globally as a solution for nicotine addiction. This move of providing inducement stock options signifies the company’s efforts to onboard and retain talent.